TOP TIERMARKET NEWSWIRE
News & sentiment

VOR BIOPHARMA INC (VOR) — News & AI sentiment

VOR BIOPHARMA INC (VOR) news roundup. 2 stories in the past week, 6 over 30 days. Average 30-day sentiment is 60/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
2
avg sentiment 69/100
30d stories
6
avg sentiment 60/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

VOR news in the last 24 hours, 7 days, 30 days and 90 days

How much VOR coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowVOR storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days269/100VOR headlines →
Last 30 days660/100VOR headlines →
Last 90 days2056.9/100VOR headlines →

Latest stories on VOR

6d ago
6d ago
Oct 21
Oct 5
Oct 5
Sep 29
Stifel reiterates Vor Biopharma stock rating on telitacicept potential
Investing.com Analyst Ratings56 · neutralanalyst
Sep 28
Sep 18
Sep 16
Sep 9
Sep 8
Sep 4
Sep 4
Sep 4
Sep 1
Aug 17
Vor Biopharma reports Q2 results
Seeking Alpha50 · neutralearnings
Aug 12
Aug 11
Aug 11
Aug 3
Jul 7
Vor Biopharma Inc. (VOR) files 8-K
SEC 8-K50 · neutralgeneral
Jul 7
Jul 7
Jul 7
Jul 2
Open VOR in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →